Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
Event Date
Wednesday, January 06, 2027
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- Triple Negative Breast Cancer Foundation
- Advanced Practitioner Society for Hematology and Oncology (APSHO)
- American Breast Cancer Foundation
- American Cancer Society
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Association of Clinicians for the Underserved
- Association of Oncology Social Work
- Black Womens Health Imperative
- Breast Cancer Alliance
- BreastCancerTrials.org
- Cancer Justice
- Cancer Nation
- Caregiver Action Network
- Cancer Support Community
- Intercultural Cancer Council
- Joe's House
- LIVESTRONG Foundation
- Living Beyond Breast Cancer
- Multinational Association of Supportive Care in Cancer
- National Association of Social Workers
- National Breast Cancer Coalition
- National Comprehensive Cancer Network (NCCN) NCCN Guidelines for Patients
- National LGBT Cancer Network
- NeedyMeds
- Prevent Cancer Foundation
- Redes en Acción The National Latino Cancer Research Network
- Research Advocacy Network
- Scott Hamilton CARES Foundation
- SHARE Cancer Support
- Sharsheret - The Jewish Breast and Ovarian Cancer Community
- Sisters Network Inc. - A National African American Breast Cancer Survivorship Organization
- Susan G. Komen
- The LGBT Cancer Project
- The National Witness Project, Inc.
- Tigerlily Foundation
- Triage Cancer
- TOUCH, The Black Breast Cancer Alliance
- Young Survival Coalition
This program is made possible by the Triple Negative Breast Cancer Foundation. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Overview of Triple Negative Breast Cancer (TNBC)
- New Research on TNBC Presented at SABCS
- TNBC-Specific Treatment Updates
- Updates on Clinical Trials Advancing Treatment Options
- The Increasing Role of Diagnostic Testing, Biomarkers, and Genetic Testing in Informing Treatment Decisions
- Investigational Therapies Currently Being Studied in Clinical Trials
- New Developments in the Prevention and Management of Treatment Side Effects, Symptoms, Discomfort, and Pain
- Communicating Effectively with the Health Care Team
- Key Questions to Ask About Treatment Adherence, Quality of Life, and Follow-Up Care
- Questions and Answers with Our Panel of Experts
Speakers
Facilitator
Facilitator
Facilitator
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please fill out the evaluation form(s), included in the email registration packet and evaluation, with your name, address, and license type after the program. For any questions or concerns you may contact us at [email protected]. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program. Forms only open AFTER the live program.